
Elliptic Laboratories ASA
OSE:ELABS

Elliptic Laboratories ASA?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
8.86
14.4
|
Price Target |
|
We'll email you a reminder when the closing price reaches NOK.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does Elliptic Laboratories ASA hold over its rivals?
What risks and challenges
does Elliptic Laboratories ASA face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Elliptic Laboratories ASA.
Provide an overview of the primary business activities
of Elliptic Laboratories ASA.
What unique competitive advantages
does Elliptic Laboratories ASA hold over its rivals?
What risks and challenges
does Elliptic Laboratories ASA face in the near future?
Summarize the latest earnings call
of Elliptic Laboratories ASA.
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Elliptic Laboratories ASA.
Provide P/S
for Elliptic Laboratories ASA.
Provide P/E
for Elliptic Laboratories ASA.
Provide P/OCF
for Elliptic Laboratories ASA.
Provide P/FCFE
for Elliptic Laboratories ASA.
Provide P/B
for Elliptic Laboratories ASA.
Provide EV/S
for Elliptic Laboratories ASA.
Provide EV/GP
for Elliptic Laboratories ASA.
Provide EV/EBITDA
for Elliptic Laboratories ASA.
Provide EV/EBIT
for Elliptic Laboratories ASA.
Provide EV/OCF
for Elliptic Laboratories ASA.
Provide EV/FCFF
for Elliptic Laboratories ASA.
Provide EV/IC
for Elliptic Laboratories ASA.
Show me price targets
for Elliptic Laboratories ASA made by professional analysts.
What are the Revenue projections
for Elliptic Laboratories ASA?
How accurate were the past Revenue estimates
for Elliptic Laboratories ASA?
What are the Net Income projections
for Elliptic Laboratories ASA?
How accurate were the past Net Income estimates
for Elliptic Laboratories ASA?
What are the EPS projections
for Elliptic Laboratories ASA?
How accurate were the past EPS estimates
for Elliptic Laboratories ASA?
What are the EBIT projections
for Elliptic Laboratories ASA?
How accurate were the past EBIT estimates
for Elliptic Laboratories ASA?
Compare the revenue forecasts
for Elliptic Laboratories ASA with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Elliptic Laboratories ASA and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Elliptic Laboratories ASA against its competitors.
Analyze the profit margins
(gross, operating, and net) of Elliptic Laboratories ASA compared to its peers.
Compare the P/E ratios
of Elliptic Laboratories ASA against its peers.
Discuss the investment returns and shareholder value creation
comparing Elliptic Laboratories ASA with its peers.
Analyze the financial leverage
of Elliptic Laboratories ASA compared to its main competitors.
Show all profitability ratios
for Elliptic Laboratories ASA.
Provide ROE
for Elliptic Laboratories ASA.
Provide ROA
for Elliptic Laboratories ASA.
Provide ROIC
for Elliptic Laboratories ASA.
Provide ROCE
for Elliptic Laboratories ASA.
Provide Gross Margin
for Elliptic Laboratories ASA.
Provide Operating Margin
for Elliptic Laboratories ASA.
Provide Net Margin
for Elliptic Laboratories ASA.
Provide FCF Margin
for Elliptic Laboratories ASA.
Show all solvency ratios
for Elliptic Laboratories ASA.
Provide D/E Ratio
for Elliptic Laboratories ASA.
Provide D/A Ratio
for Elliptic Laboratories ASA.
Provide Interest Coverage Ratio
for Elliptic Laboratories ASA.
Provide Altman Z-Score Ratio
for Elliptic Laboratories ASA.
Provide Quick Ratio
for Elliptic Laboratories ASA.
Provide Current Ratio
for Elliptic Laboratories ASA.
Provide Cash Ratio
for Elliptic Laboratories ASA.
What is the historical Revenue growth
over the last 5 years for Elliptic Laboratories ASA?
What is the historical Net Income growth
over the last 5 years for Elliptic Laboratories ASA?
What is the current Free Cash Flow
of Elliptic Laboratories ASA?
Discuss the annual earnings per share (EPS)
trend over the past five years for Elliptic Laboratories ASA.
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
Market Cap | EV/EBITDA | ||||
---|---|---|---|---|---|
NO |
![]() |
Elliptic Laboratories ASA
OSE:ELABS
|
1.4B NOK | 45.3 | |
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
372.4B USD | 843 |
|
DE |
![]() |
SAP SE
XETRA:SAP
|
285.8B EUR | 26.9 |
|
US |
![]() |
Salesforce Inc
NYSE:CRM
|
258.2B USD | 22 |
|
US |
![]() |
Intuit Inc
NASDAQ:INTU
|
219.8B USD | 40.1 |
|
US |
N
|
NCR Corp
LSE:0K45
|
190.8B USD | 595.9 |
|
US |
![]() |
Adobe Inc
NASDAQ:ADBE
|
157.9B USD | 18.1 |
|
US |
![]() |
Applovin Corp
NASDAQ:APP
|
123.2B USD | 45 |
|
US |
![]() |
Microstrategy Inc
NASDAQ:MSTR
|
108B USD | -3 374.9 |
|
US |
![]() |
Synopsys Inc
NASDAQ:SNPS
|
93.3B USD | 56.8 |
|
US |
![]() |
Cadence Design Systems Inc
NASDAQ:CDNS
|
90.7B USD | 53.1 |
|
EBITDA Growth | EV/EBITDA to Growth | |||||
---|---|---|---|---|---|---|
NO |
![]() |
Elliptic Laboratories ASA
OSE:ELABS
|
Average EV/EBITDA:
174.6
45.3
|
131%
|
0.3 | |
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
843
|
109%
|
7.7 |
|
DE |
![]() |
SAP SE
XETRA:SAP
|
26.9
|
19%
|
1.4 |
|
US |
![]() |
Salesforce Inc
NYSE:CRM
|
22
|
24%
|
0.9 |
|
US |
![]() |
Intuit Inc
NASDAQ:INTU
|
40.1
|
28%
|
1.4 |
|
US |
N
|
NCR Corp
LSE:0K45
|
595.9
|
12%
|
49.7 |
|
US |
![]() |
Adobe Inc
NASDAQ:ADBE
|
18.1
|
17%
|
1.1 |
|
US |
![]() |
Applovin Corp
NASDAQ:APP
|
45
|
42%
|
1.1 |
|
US |
![]() |
Microstrategy Inc
NASDAQ:MSTR
|
Negative Multiple: -3 374.9 | N/A | N/A |
|
US |
![]() |
Synopsys Inc
NASDAQ:SNPS
|
56.8
|
34%
|
1.7 |
|
US |
![]() |
Cadence Design Systems Inc
NASDAQ:CDNS
|
53.1
|
27%
|
2 |
|
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.